These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 28717351)

  • 41. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury.
    Žurek J; Fedora M
    Acta Neurochir (Wien); 2012 Jan; 154(1):93-103; discussion 103. PubMed ID: 21976236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.
    Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O
    World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI.
    Berger RP; Hayes RL; Richichi R; Beers SR; Wang KK
    J Neurotrauma; 2012 Jan; 29(1):162-7. PubMed ID: 22022780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Point-of-Care Platform Blood Biomarker Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study.
    Okonkwo DO; Puffer RC; Puccio AM; Yuh EL; Yue JK; Diaz-Arrastia R; Korley FK; Wang KKW; Sun X; Taylor SR; Mukherjee P; Markowitz AJ; Jain S; Manley GT;
    J Neurotrauma; 2020 Dec; 37(23):2460-2467. PubMed ID: 32854584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebral Expression of Glial Fibrillary Acidic Protein, Ubiquitin Carboxy-Terminal Hydrolase-L1, and Matrix Metalloproteinase 9 After Traumatic Brain Injury and Secondary Brain Insults in Rats.
    Mrozek S; Delamarre L; Capilla F; Al-Saati T; Fourcade O; Constantin JM; Geeraerts T
    Biomark Insights; 2019; 14():1177271919851515. PubMed ID: 31210728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
    Park SH; Hwang SK
    World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Narrative Review of Existing and Developing Biomarkers in Acute Traumatic Brain Injury for Potential Military Deployed Use.
    Kocik VI; Dengler BA; Rizzo JA; Ma Moran M; Willis AM; April MD; Schauer SG
    Mil Med; 2024 May; 189(5-6):e1374-e1380. PubMed ID: 37995274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-Effectiveness of Blood-Based Brain Biomarkers for Screening Adults with Mild Traumatic Brain Injury in the French Health Care Setting.
    Zimmer L; McDade C; Beyhaghi H; Purser M; Textoris J; Krause A; Blanc E; Pavlov V; Earnshaw S
    J Neurotrauma; 2023 Apr; 40(7-8):706-719. PubMed ID: 36267001
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Finding effective biomarkers for pediatric traumatic brain injury.
    Glushakova OY; Glushakov AV; Hayes RL
    Brain Circ; 2016; 2(3):129-132. PubMed ID: 30276288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biofluid biomarkers of traumatic brain injury.
    Agoston DV; Shutes-David A; Peskind ER
    Brain Inj; 2017; 31(9):1195-1203. PubMed ID: 28981341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Brain Injury Biomarkers and Circulatory Shock Following Moderate-Severe Traumatic Brain Injury: A TRACK-TBI Study.
    Toro C; Jain S; Sun S; Temkin N; Barber J; Manley G; Komisarow JM; Ohnuma T; Foreman B; Korley F; James ML; Laskowitz D; Vavilala MS; Hernandez A; Mathew JP; Markowitz AJ; Krishnamoorthy V;
    J Neurosurg Anesthesiol; 2023 Jul; 35(3):284-291. PubMed ID: 34967764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
    Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
    J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light.
    Al Nimer F; Thelin E; Nyström H; Dring AM; Svenningsson A; Piehl F; Nelson DW; Bellander BM
    PLoS One; 2015; 10(7):e0132177. PubMed ID: 26136237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III Trial.
    Korley F; Pauls Q; Yeatts SD; Jones CMC; Corbett-Valade E; Silbergleit R; Frankel M; Barsan W; Cahill ND; Bazarian JJ; Wright DW
    J Neurotrauma; 2021 Jul; 38(14):1953-1960. PubMed ID: 33319651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.
    Berger RP; Pierce MC; Wisniewski SR; Adelson PD; Clark RS; Ruppel RA; Kochanek PM
    Pediatrics; 2002 Feb; 109(2):E31. PubMed ID: 11826241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study protocol for investigating the clinical performance of an automated blood test for glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase L1 blood concentrations in elderly patients with mild traumatic BRAIN Injury and reference values (BRAINI-2 Elderly European study): a prospective multicentre observational study.
    Lagares A; Payen JF; Biberthaler P; Poca MA; Méjan O; Pavlov V; Viglino D; Sapin V; Lassaletta A; de la Cruz J;
    BMJ Open; 2023 Jul; 13(7):e071467. PubMed ID: 37460257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. UCH-L1 is a Poor Serum Biomarker of Murine Traumatic Brain Injury After Polytrauma.
    Morris MC; Bercz A; Niziolek GM; Kassam F; Veile R; Friend LA; Pritts TA; Makley AT; Goodman MD
    J Surg Res; 2019 Dec; 244():63-68. PubMed ID: 31279265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating Brain Injury Exosomal Proteins following Moderate-To-Severe Traumatic Brain Injury: Temporal Profile, Outcome Prediction and Therapy Implications.
    Mondello S; Guedes VA; Lai C; Czeiter E; Amrein K; Kobeissy F; Mechref Y; Jeromin A; Mithani S; Martin C; Wagner CL; Czigler A; Tóth L; Fazekas B; Buki A; Gill J
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients.
    Baker AJ; Rhind SG; Morrison LJ; Black S; Crnko NT; Shek PN; Rizoli SB
    J Neurotrauma; 2009 Aug; 26(8):1227-40. PubMed ID: 19637968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum Tau, Neurofilament Light Chain, Glial Fibrillary Acidic Protein, and Ubiquitin Carboxyl-Terminal Hydrolase L1 Are Associated with the Chronic Deterioration of Neurobehavioral Symptoms after Traumatic Brain Injury.
    Lange RT; Lippa S; Brickell TA; Gill J; French LM
    J Neurotrauma; 2023 Mar; 40(5-6):482-492. PubMed ID: 36170576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.